Navigation Links
BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards
Date:10/1/2007

NAAS, Ireland, Oct. 1 /PRNewswire/ -- A highly sensitive, easy-to-use test that accurately detects bovine viral diarrhea virus (BVDV) was selected as the Best New Veterinary Product for Diagnostics in the annual Animal Pharm Awards. BoVir(R) BVDV real time PCR test was selected for its excellence and innovation by an independent judging panel representing members of the global community of animal sciences practitioners and professionals. The award was presented September 25, 2007, during a black-tie ceremony at Gibson Hall, London, UK.

The newly available BVDV test was developed by AnDiaTec GmbH of Germany, and is distributed globally by Enfer Diagnostics. According to Animal Pharm, the worldwide news service for the animal health industries and sponsor of the competition, "the panel of judges believed that BoVir made eradication of BVDV a realistic option for cattle producers."

"We are very pleased that BoVir(R) has been recognized as a diagnostic test that provides veterinarians, laboratories, and herd managers with an accurate, one-step, and cost-effective solution for successful BVDV eradication," said AnDiaTec developmental geneticist and company owner, Dr. Johannes Kehle upon accepting the award. "Now a farmer can be sure that BVDV detection is early, accurate, and reliable."

According to the judges, BoVir(R) was selected as best in the diagnostic category for its ability to address the four key issues that make current BVDV detection problematic -- the test is easy to use, it's highly sensitive and specific, it provides unprecedented early detection of the virus, and it produces the most advanced genotype and strain diversity detection.

"Our unique, proprietary lysis buffer eliminates the need for the costly, labor-intensive, and time-consuming RNA extraction step, which further eliminates the complicated error-prone steps often associated with inhibiting high throughput molecular labs," said Dr. Kehle. "In addition, BoVir(R)'s ability to detect all 68 referenced strains provides the vet lab, veterinarian, and farmer the confidence that positives will be detected and that negatives are actually negatives."

The award acceptance by AnDiaTec and Enfer Diagnostics was followed by a September 26, 2007, grand opening celebration of the new Enfer Diagnostics Research and Operations Center in Naas, Ireland. The 50,000 square-foot vet diagnostics manufacturing, logistics, customer training, customer service and operations center also provides services focused on vet diagnostic research and development, European and global technical support, lab process integration testing and validation, and lab diagnostic training. The center also serves as an industry partner alignment center and expects to employ over 300 workers within the next 24 to 30 months.

"Enfer Diagnostics is committed to exceeding the needs of the large animal producer and the veterinary diagnostic laboratories with our world-class Enfer Diagnostics Research and Operations Center," stated Cliff Cain, Enfer Diagnostics President. "Animal Pharm's independent review and subsequent 2007 New Product of the Year award validates our decision to bring state-of-the-art molecular diagnostic products for use in large-animal production operations."

More than 200 local, national, and international dignitaries attended the grand opening, including key veterinary opinion leaders and Ireland's Prime Minister Bertie Ahearn.

AnDiaTec GmbH & Co. (http://www.andiatec.com) is a privately held company located near Stuttgart, Germany. The company specializes in unique and proprietary reagents for use in human and veterinary diagnostics and detection systems, and performs environmental analytics under commercial lab services.

Headquartered in Naas, Ireland, Enfer Diagnostics (http://www.enferdiagnostics.com) is a specialized provider of advanced diagnostics to improve animal disease management worldwide. Enfer is the first biotechnology company worldwide to develop a rapid test screening system for bovine spongiform encephalopathy (BSE). Recognized by industry and working to observe the needs of government agencies, Enfer Diagnostics is committed to delivering only the most accurate diagnostics that disease eradication demands. Its worldwide diagnostics distribution also includes BSE screening, and ParaTub(R), an automated, high throughput test for the detection of Mycobacterium paratuberculosis (Johne's disease), an incurable cattle infection impacting the beef and dairy cattle industry.

For more information on the annual Animal Pharm awards, visit http://www.animalpharmawards.com.


'/>"/>
SOURCE Enfer Diagnostics
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Bruce Maas named CIO at UW-Milwaukee
2. Three finalists named for UW-Madison CIO
3. Eight lawmakers named to Speakers IT task force
4. Hospital named for Madame Curie installs TomoTherapy system
5. Two UW-Madison professors named to National LambdaRail Networking Research Council
6. UW researcher named top innovator
7. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
8. Inacom named Microsofts favorite learning solutions partner of the year
9. Five Wisconsin CIOs named top in nation
10. Deltanoid named to top-15 list of biotech companies
11. Roche Diagnostics Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016   Ginkgo Bioworks , a leading ... was today awarded as one of the World ... world,s most innovative companies. Ginkgo Bioworks is engineering ... real world in the nutrition, health and consumer ... with customers including Fortune 500 companies to design ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
Breaking Biology Technology:
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
Breaking Biology News(10 mins):